https://www.globenewswire.com/news-release/2019/11/18/1948686/0/en/Corbus-Pharmaceuticals-Completes-Enrollment-of-Phase-2b-Study-of-Lenabasum-for-Treatment-of-Cystic-Fibrosis.html
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis